- Clinical Trials
- November 2024
- 60 Pages
Global
From €1185EUR$1,250USD£990GBP
- Report
- June 2024
- 200 Pages
Global
From €7535EUR$7,950USD£6,295GBP
- Report
- January 2022
- 60 Pages
Global
From €3744EUR$3,950USD£3,128GBP
- Report
- July 2022
- 92 Pages
Global
From €1896EUR$2,000USD£1,584GBP
The Yellow Fever Drug market is a subset of the larger Infectious Diseases Drugs market. It is composed of drugs used to treat and prevent yellow fever, a viral infection spread by mosquitoes. These drugs are typically administered as a single dose and are effective in preventing the disease in most cases. Vaccines are the most common form of yellow fever drug, although antiviral medications are also available. Vaccines are typically administered to travelers visiting areas where yellow fever is endemic, as well as to those living in areas where the disease is common.
The Yellow Fever Drug market is highly competitive, with a number of companies offering products. These include Sanofi Pasteur, GlaxoSmithKline, Merck, and Johnson & Johnson. Other companies, such as Bharat Biotech, have recently entered the market with their own vaccines. Show Less Read more